Raloxifene
Medication Facts
- Performance enhancing
- Yes
- Total hours to clear
- Not recorded
- Frequently used
- N/A
- ESC ID
- RALOXI-0784
- Trade names
- N/A
- Drug type
- Selective estrogen receptor modulator
- Plasma half-life · hours
- Not Published
- Equine dosing
- Not Published
- Cmax · peak plasma concentration
- N/A
- Tmax · time to peak plasma concentration
- N/A
- ESC concentration guidance
- Lowest Dectable Level (LDL) 0.05 mg/mL or 50 picograms per mL
- Primary withdrawal · hours
- 48
- Washout withdrawal · hours
- 0
- ESC control type
- C1 - Strictly Controlled - Restricted - Performance
- Medication report required
- MED REPORT REQUIRED
Uses & side effects
No known medical use
Product-specific side effects await source review.
Drug interactions
Raloxifene is not approved or commonly used as a medication for horses in veterinary medicine. While it is an FDA-approved drug for human use to treat osteoporosis and reduce breast cancer risk, it has no established clinical purpose or proven safety profile for equine patients.Veterinarians studying Selective Estrogen Receptor Modulators (SERMs) in horses generally look at them strictly in a research context, such as evaluating how their chemical compounds are broken down by the liver or testing their pharmacokinetics.There are several important points regarding its use in the equestrian world:No Veterinary Indications: Unlike humans, horses do not suffer from the same type of postmenopausal osteoporosis that raloxifene is designed to treat.Regulatory Bans: In competitive equine sports, SERMs are strictly monitored. Organizations like the Fédération Équestre Internationale (FEI) and racing commissions often list these medications as controlled or outright banned substances. Unapproved use can lead to serious sanctions and disqualifications.Similar Human Medications: Instead of raloxifene, equine veterinarians rely on different classes of drugs entirely—such as bisphosphonates (e.g., Tildren or Osphos)—to manage specific bone-related conditions, like navicular disease in horses.